Skip to main content
. 2023 Jul 26;8(31):28233–28248. doi: 10.1021/acsomega.3c01571

Table 2. Features of the Developed NEGs.

formulations drug content (%) homogeneity spreadability (cm) droplet size (nm) pH viscosity (cps)
20% clove-oil–NEG 98.5 ± 2.2 clear, uniform, no aggregates 4.12 ± 0.23 67 ± 3.4 6.5 9394
15% eucalyptus-oil–NEG 98.8 ± 3.4 clear, uniform, no aggregates 4.32 ± 0.17 78 ± 5.2 6.6 9456